Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Key Points

• Short interest for Advanced Medical Isotope Corporation (OTCMKTS:RDGL) decreased by 80.4% in July, dropping to 8,800 shares from 44,800 shares mid-month.
• As of the latest report, approximately 0.0% of the company's stock is short sold, indicating very low short selling activity.
• Shares of Advanced Medical Isotope stock are currently trading at $0.09, with a 52-week range between $0.04 and $0.18.

Advanced Medical Isotope Corporation (OTCMKTS:RDGL - Get Free Report) was the recipient of a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 8,800 shares, adropof80.4% from the July 15th total of 44,800 shares. Approximately0.0% of the company's shares are sold short. Based on an average daily volume of 3,229,300 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 3,229,300 shares, the days-to-cover ratio is currently 0.0 days. Approximately0.0% of the company's shares are sold short.

Advanced Medical Isotope Stock Up 4.3%

RDGL traded up $0.0034 on Wednesday, hitting $0.0824. The company had a trading volume of 1,532,108 shares, compared to its average volume of 3,168,912. The company's fifty day moving average price is $0.12 and its 200 day moving average price is $0.12. Advanced Medical Isotope has a 1 year low of $0.0425 and a 1 year high of $0.1840.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals.